G. Michael Wall
No más puestos en curso
Perfil
G.
Michael Wall worked as a Vice President-Product Development at Otonomy, Inc. before pursuing his education.
He holds a graduate degree from Auburn University and a doctorate from the University of Mississippi.
Antiguos cargos conocidos de G. Michael Wall.
| Empresas | Cargo | Fin |
|---|---|---|
| OTONOMY | Corporate Officer/Principal | - |
Formación de G. Michael Wall.
| University of Mississippi | Doctorate Degree |
| Auburn University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- G. Michael Wall
